Skip to main content
Clinical Trials/NCT02834221
NCT02834221
Completed
Not Applicable

Ultrasound-guided or Anatomical Femoral Venipuncture for Pulmonary Vein Isolation for Atrial Fibrillation Treatment

Kenichiro Yamagata4 sites in 2 countries320 target enrollmentJune 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
Kenichiro Yamagata
Enrollment
320
Locations
4
Primary Endpoint
Major complications
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This study is designed to evaluate the use of real-time ultrasound-guided femoral venipuncture during pulmonary vein isolation for treating atrial fibrillation .

Detailed Description

The number of pulmonary vein isolation (PVI) therapy for atrial fibrillation (AF) is increasing. Multiple femoral vein cannulation is mandatory for this procedure. There are mainly two methods to cannulate the femoral vein; by anatomical landmark or by under real-time ultrasound-guided. As high anticoagulant level is required for the procedure, there are 0-13% of vascular access complication. Real-time ultrasound assistance for central venous catheter cannulation has been proven to reduce complications. In the field of AF treatment, multiple femoral vein cannulation is required as many catheter is required for the procedure and larger sheaths are inserted with a high anticoagulant level during the procedure. In this setting, the use of ultrasound use is not well studied. The current study is to confirm whether real time ultrasound-guided femoral vein cannulation for PVI can prevent complications, reduce puncture time, puncture attempts and accidental artery puncture compared to conventional anatomical approach. Two seethes for each femoral vein is going to be cannulated. The study design is a multicenter prospective randomized trial to compare the above safety and efficacy by using the ultrasound-guided and anatomical landmark approach. Also time for cannulation, number of puncture attempts, need of X-ray for cannulation will be analyzed in the setting of patient factors including age, body mass index and sex.

Registry
clinicaltrials.gov
Start Date
June 2016
End Date
November 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Kenichiro Yamagata
Responsible Party
Sponsor Investigator
Principal Investigator

Kenichiro Yamagata

MD, PhD

Institute for Clinical and Experimental Medicine

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing pulmonary vein isolation with radiofrequency catheter ablation for atrial fibrillation treatment.

Exclusion Criteria

  • Patients with prior known vascular access problems or priory included to the current study.

Outcomes

Primary Outcomes

Major complications

Time Frame: After the puncture up to 12 weeks

Total patient number of vascular complications requiring surgical treatment, retroperitoneal hematoma requiring blood transfusion or hemoglobin drop of 3 \>g/dl, strong pain at the groin, prolonging hospital stay and requiring hospital admission after discharge.

Secondary Outcomes

  • Unsuccessful femoral vein cannulation(Immediately after the puncture)
  • Number of artery mis-punctures(Immediately after the puncture)
  • Use of X-ray for successful wire cannulation(Immediately after the puncture)
  • Number of puncture attempts(Immediately after the puncture)
  • Total puncture time(Immediately after the puncture)

Study Sites (4)

Loading locations...

Similar Trials